今海醫療科技(02225.HK)盈警:預期年度淨虧損350萬至450萬新加坡元
格隆匯3月22日丨今海醫療科技(02225.HK)發佈公吿,公司預期截至2023年12月31日止年度將錄得3.5百萬新加坡元至4.5百萬新加坡元的淨虧損,而上年度則為淨利潤0.12百萬新加坡元。
預期由淨利潤轉為淨虧損狀況主要歸因於下列原因:1.董事會先前重新評估業務重點及策略方向後,集團積極在中國發展微創手術解決方案領域及相關醫療產品及服務。因此,產生了若干早期產品開發及測試製造成本。於報吿期間有關金額約為1.15百萬新加坡元,而上年度約為0.60百萬新加坡元。2.於報吿期間,就微創手術解決方案業務而言,集團為支持新業務發展而產生了額外的一般及行政開支,包括聘請相關行業資深人士及其他配套員工、租用額外合適場地用於微創手術解決方案相關產品的研發、製造及營銷。因此,於報吿期間的一般及行政開支為0.91百萬新加坡元,而上年度,集團產生的開支約為0.70百萬新加坡元。3.於報吿期間,為支持新微創手術解決方案業務,集團產生了額外的推廣及營銷開支。於報吿期間的開支約為1.72百萬新加坡元,而上年度約為0.17百萬新加坡元。4.就集團的海外人力資源及宿舍服務業務而言,集團於報吿期間內向管理層支付若干激勵績效花紅以表彰業務改善。有關金額約為2.5百萬新加坡元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.